Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willi Amberg

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|September 26, 2008
Inhibitors of GlyT1 affect glycine transport via discrete binding sitesMario Mezler, Wilfried Hornberger, Reinhold Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Solid-phase synthesis of endothelin receptor antagonistsUdo E W Lange, Wilfried M Braje, Willi Amberg, et al.
Journal of Biomolecular Screening|February 8, 2005
An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPRSujatha M Gopalakrishnan, Betsy Mammen, Martin Schmidt, et al.
Drug Discovery Today|March 7, 2018
Computational prediction of chemical reactions: current status and outlookOla Engkvist, Per-Ola Norrby, Nidhal Selmi, et al.
Journal of Medicinal Chemistry|July 4, 2018
De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive InhibitorsYing Wang, Hongyu Zhao, Jason T Brewer, et al.
European Journal of Pharmacology|October 3, 2022
Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brainMartina P Morawe, Fan Liao, Willi Amberg, et al.
Journal of Medicinal Chemistry|August 7, 2018
Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) InhibitorsWilli Amberg, Udo E W Lange, Michael Ochse, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|September 26, 2008
Inhibitors of GlyT1 affect glycine transport via discrete binding sitesMario Mezler, Wilfried Hornberger, Reinhold Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Solid-phase synthesis of endothelin receptor antagonistsUdo E W Lange, Wilfried M Braje, Willi Amberg, et al.
Journal of Biomolecular Screening|February 8, 2005
An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPRSujatha M Gopalakrishnan, Betsy Mammen, Martin Schmidt, et al.
Drug Discovery Today|March 7, 2018
Computational prediction of chemical reactions: current status and outlookOla Engkvist, Per-Ola Norrby, Nidhal Selmi, et al.
Journal of Medicinal Chemistry|July 4, 2018
De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive InhibitorsYing Wang, Hongyu Zhao, Jason T Brewer, et al.
European Journal of Pharmacology|October 3, 2022
Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brainMartina P Morawe, Fan Liao, Willi Amberg, et al.
Journal of Medicinal Chemistry|August 7, 2018
Discovery of Novel Aminotetralines and Aminochromanes as Selective and Competitive Glycine Transporter 1 (GlyT1) InhibitorsWilli Amberg, Udo E W Lange, Michael Ochse, et al.
Heliyon|September 10, 2024
Navitoclax safety, tolerability, and effect on biomarkers of senescence and neurodegeneration in aged nonhuman primatesEdward F Greenberg, Martin J Voorbach, Alexandra Smith, et al.
Pageof 1